BNP PARIBAS FINANCIAL MARKETS - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$6
-45.5%
30.0%0.00%
Q2 2023$11
+10.0%
30.0%0.00%
Q1 2023$10
-98.2%
3
-99.1%
0.00%
Q4 2022$541
-99.9%
3490.0%0.00%
Q3 2022$475,000
-93.6%
349
-89.8%
0.00%
Q2 2022$7,468,000
-37.6%
3,410
-9.1%
0.00%
Q1 2022$11,966,000
-68.2%
3,751
-58.2%
0.00%
Q4 2021$37,618,000
-39.0%
8,978
+18.2%
0.00%
Q3 2021$61,671,000
+453.8%
7,595
+414.9%
0.00%
Q2 2021$11,136,000
-75.9%
1,475
-72.2%
0.00%
Q1 2021$46,126,000
-21.6%
5,314
-28.0%
0.00%
Q4 2020$58,819,000
-19.0%
7,380
-19.0%
0.00%
Q3 2020$72,636,000
+520.7%
9,108
+670.6%
0.00%
Q2 2020$11,702,000
-84.0%
1,182
-87.5%
0.00%
Q1 2020$72,933,000
+344.1%
9,435
+121.2%
0.00%
Q4 2019$16,424,000
-32.2%
4,266
-11.4%
0.00%
Q3 2019$24,224,000
+8.0%
4,816
+42.0%
0.00%
Q2 2019$22,421,000
-52.2%
3,392
-45.2%
0.00%
Q1 2019$46,881,000
+291.6%
6,193
+567.3%
0.00%
Q3 2018$11,971,000
+13.2%
9280.0%0.00%
Q2 2018$10,579,0009280.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders